Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas

Abstract : Molecular and clinical heterogeneity critically hinders better treatment outcome for glioblastomas (GBMs); integrative analysis of genomic and epigenomic data may provide useful information for improving personalized medicine. By applying training-validation approach, we identified a novel hypomethylation signature comprising of three CpGs at non-CpG island (CGI) open sea regions for GBMs. The hypomethylation signature consistently predicted poor prognosis of GBMs in a series of discovery and validation datasets. It was demonstrated as an independent prognostic indicator, and showed interrelationships with known molecular marks such as MGMT promoter methylation status, and glioma CpG island methylator phenotype (G-CIMP) or IDH1 mutations. Bioinformatic analysis found that the hypomethylation signature was closely associated with the transcriptional status of an EGFR/VEGFA/ANXA1-centered gene network. The integrative molecular analysis finally revealed that the gene network defined two distinct clinically relevant molecular subtypes reminiscent of different immature neuroglial lineages in GBMs. The novel hypomethylation signature and relevant gene network may provide new insights into prognostic classification, molecular characterization, and treatment development for GBMs.
Type de document :
Article dans une revue
Oncotarget, Impact journals, 2017, 8 (52), pp.89607-89619. 〈10.18632/oncotarget.19171〉
Liste complète des métadonnées

Littérature citée [48 références]  Voir  Masquer  Télécharger
Contributeur : Xavier Chard-Hutchinson <>
Soumis le : mercredi 31 janvier 2018 - 10:08:34
Dernière modification le : mercredi 16 mai 2018 - 11:23:52
Document(s) archivé(s) le : mardi 1 mai 2018 - 13:22:20


Yin - Integrative analysis of ...
Fichiers éditeurs autorisés sur une archive ouverte



A. Yin, A. Etcheverry, Y. He, M. Aubry, J. Barnholtz-Sloan, et al.. Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas. Oncotarget, Impact journals, 2017, 8 (52), pp.89607-89619. 〈10.18632/oncotarget.19171〉. 〈hal-01647188〉



Consultations de la notice


Téléchargements de fichiers